Relationship between thiol, disulphide volume and contrast-induced nephropathy in acute coronary syndrome patients treated with percutaneous coronary intervention

References

• Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105(5):624–628.
   PubMed Web of Science ®Google Scholar
• Oksuz F, Yarlioglues M, Cay S, et al. Predictive value of gamma-glutamyl transferase levels for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Am J Cardiol. 2015;116(5):711–716.
   PubMed Web of Science ®Google Scholar
• Jarai R, Dangas G, Huber K, et al. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial. Circ Cardiovasc Interv. 2012;5(6):813–820.
   PubMed Web of Science ®Google Scholar
• Fox CS, Muntner P, Chen AY, et al. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation. 2012;125(3):497–504.
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172(11):1461–1471.
   PubMed Web of Science ®Google Scholar
• Azzalini L, Spagnoli V, Ly HQ. Contrast-Induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol. 2016;32(2):247–255.
   PubMed Web of Science ®Google Scholar
• Ortega LM, Harmouch I, Nayer A. Contrast-induced nephropathy: pathogenesis and new therapeutic options for prevention. Am J Ther. 2015;22(6):469–476.
   PubMed Web of Science ®Google Scholar
• Altıparmak IH, Erkuş ME, Sezen H, et al. The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. Kardiol Pol. 2016;74:1346–1353.
   PubMed Web of Science ®Google Scholar
• Kiziltunc E, Gok M, Kundi H, et al. Plasma thiols and thiol-disulfide homeostasis in patients with isolated coronary artery ectasia. Atherosclerosis. 2016;253:209–213.
   PubMed Web of Science ®Google Scholar
• Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem. 2013;288(37):26489–26496.
   PubMed Web of Science ®Google Scholar
• Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr. 2000;72(2 Suppl):653–669.
   PubMed Web of Science ®Google Scholar
• Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol. 2006;71(5):551–564.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, ESC Committee for Practice Guidelines (CPG), et al. ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Yarlioglues M, Duran M. Predictive value of CHA2DS2-VASC Score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2017;119(6):819–825.
   PubMed Web of Science ®Google Scholar
• Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326–332.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, European Association of Echocardiography, European Society of Cardiology, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Bassand JP, Agewall S, ESC Committee for Practice Guidelines, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999–3054.
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36(5):1542–1548.
   PubMed Web of Science ®Google Scholar
• James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6(1):37–43.
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399.
   PubMed Web of Science ®Google Scholar
• Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.
   PubMed Web of Science ®Google Scholar
• Kaya A, Kaya Y, Topçu S, et al. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(1):51–56.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82(2):291–295.
   PubMed Web of Science ®Google Scholar
• Nickenig G, Harrison DG. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation. 2002;105(3):393–396.
   PubMed Web of Science ®Google Scholar
• Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond). 2005;109(3):217–226.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chun OK, Song WO. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients. 2013;5(8):2969–3004.
   PubMed Web of Science ®Google Scholar
• Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840–844.
   PubMed Web of Science ®Google Scholar
• Ishibashi T. Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases . Curr Pharm Des. 2013;19(35):6375–6381.
   PubMed Web of Science ®Google Scholar
• Agan V, Celik H, Eren MA, et al. An investigation of oxidative stress and thiol/disulphide homeostasis in Graves' disease. Medicina (Kaunas). 2019;55(6):275.
   Web of Science ®Google Scholar
• Kundi H, Ates I, Kiziltunc E, et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567–1571.
   PubMed Web of Science ®Google Scholar
• Ziegler DM. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem. 1985;54:305–329.
   PubMed Web of Science ®Google Scholar
• Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148(4):284–294.
   PubMed Web of Science ®Google Scholar
• Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95(1):13–19.
   PubMed Web of Science ®Google Scholar